Article
05 Dec 2024
Update On Pending Denosumab BPCIA Litigations
AUTHORS CONTENT
Article
28 Oct 2024
GlaxoSmithKline And Northwestern Sue Moderna For Patent Infringement In Trio Of Lawsuits
Article
19 Sep 2024
WHO Prequalifies Bavarian Nordic's MVA-BN As First Vaccine Against Mpox
Article
17 Jan 2024
Issue 43: PTAB Trial Tracker
Article
20 Dec 2023
FDA Approves First Cell-Based Therapies For Treatment Of Sickle Cell Disease
Article
31 Jul 2023
Sandoz Invests In New Biosimilar Manufacturing Facility
Article
15 Mar 2023
Janssen Seeks A Preliminary Injunction In BPCIA Ustekinumab Case Against Amgen
Article
02 Nov 2022
Biogen Seeks A Preliminary Injunction In Natalizumab BPCIA Case Against Sandoz
Article
10 Aug 2022
Denosumab Clinical Trial Updates
Article
11 Jul 2022
Mylan Voluntarily Recalls Additional Batch Of Biosimilar Insulin Glargine Pens Due To Potential Missing Labels